Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.2606
Abstract: Transthyretin amyloid cardiomyopathy (ATTR‐CM) is an increasingly diagnosed disease. Echocardiography is widely utilized, but studies to confirm the value of echocardiography for tracking changes over time are not available. We sought to describe (i) changes… read more here.
Keywords: progression; prognosis transthyretin; progression echocardiographic; transthyretin cardiac ... See more keywords